Skip To Main Content
Rajesh Kumar Boggavarapu on Muck Rack

Rajesh Kumar Boggavarapu

As seen in: Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rajesh Kumar

Contact Rajesh Kumar, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Preclinical Pharmacokinetics of Erdafitinib, an FGFR Tyrosine Kinase Inhibitor, via LC-MS/MS in Sprague Dawley Rats

|
By Rajesh Kumar Boggavarapu, Jithendra Chimakurthy
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the finding of this study are available from the corresponding author upon reasonable request. Due to confidentiality agreements considerations, the data are not publicly available. Interested researchers may contact the authors to discuss access conditions and potential data sharing agreements.
Open in Who Shared Issue with article?

Validated LC-MS/MS Method for the Quantitative Determination and Pharmacokinetic Profiling of Fedratinib (TG101348), an Oral JAK2 Inhibitor, in CD1 Mice Plasma - Boggavarapu - 2026 - Biomedical Chromatography - Wiley Online Library

|
By Vishwottam Kandikere, Jithendra Chimakurthy, Rajesh Kumar Boggavarapu
| Wiley Online Library Verified
Conflicts of Interest The authors declare no conflicts of interest. Data Availability Statement The data that support the findings of this study are available from the corresponding author upon reasonable request. Due to confidentiality agreement considerations, the data are not publicly available. Interested researchers may contact the authors to discuss access conditions and potential data-sharing agreements. References , , , et al. 2023.
Open in Who Shared Issue with article?
See all 2 articles